Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CTOR
HYPR
Add up to 3 more stocks
CTOR
Citius Oncology, Inc.
-2.69%
$0.85-0.02Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$79.03M
52W Range
$0.49 - $2.25
HYPR
Hyperfine, Inc.
-1.46%
$0.87-0.01Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$73.27M
52W Range
$0.75 - $2.22
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | 8.50 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.96 | 1.99 |
| P/S Ratio | 11.12 | 4.43 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 51.4% |
| Operating Margin | 0.0% | -273.4% |
| Net Margin | -648.3% | -210.8% |
| ROE | -114.1% | -94.8% |
| ROA | -41.1% | -55.3% |
| ROIC | -88.7% | -63.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.73 | 6.15 |
| Quick Ratio | 0.34 | 5.45 |
| Debt/Equity | 0.25 | 0.36 |
| Interest Coverage | -107.89 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.